All AbMole products are for research use only, cannot be used for human consumption.
Pimecrolimus is an immunomodulating agent used in the treatment of atopic dermatitis. Pimecrolimus binds to macrophilin-12(also referred to as FKBP-12) and inhibits calcineurin in vitro. Pimecrolimus inhibits T-cell activation by inhibiting the synthesis and release of cytokines from T-cells.
| Molecular Weight | 810.45 |
| Formula | C43H68ClNO11 |
| CAS Number | 137071-32-0 |
| Solubility (25°C) | DMSO 120 mg/mL Ethanol 100 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] T Luger, et al. Topical therapy of atopic dermatitis with a focus on pimecrolimus
[2] Matthew Ladda, et al. Off-label Uses of Topical Pimecrolimus
[3] Jean Ayer, et al. Pimecrolimus for psoriasis
| Related Immunology/Inflammation Products |
|---|
| SMS121
SMS121 is a novel CD36 inhibitor. SMS121 reduced the uptake of fatty acid into AML cells that could be reversed by addition of free fatty acids and caused decreased cell viability. |
| Rolistobart
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. |
| Gemtuzumab
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin. |
| Cyclosporin A-d4
Cyclosporin A-d4 |
| Mycophenolic acid-13c,d3
Mycophenolic acid-13c,d3 |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
